Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.
about
Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and managementDuration of antibody response following vaccination against feline immunodeficiency virus.Feline leukemia and feline immunodeficiency virus in Canada - A comment.The Comparative Value of Feline Virology Research: Can Findings from the Feline Lentiviral Vaccine Be Translated to Humans?Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine.
P2860
Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Dual-subtype feline immunodefi ...... gainst heterologous challenge.
@en
Dual-subtype feline immunodefi ...... gainst heterologous challenge.
@nl
type
label
Dual-subtype feline immunodefi ...... gainst heterologous challenge.
@en
Dual-subtype feline immunodefi ...... gainst heterologous challenge.
@nl
prefLabel
Dual-subtype feline immunodefi ...... gainst heterologous challenge.
@en
Dual-subtype feline immunodefi ...... gainst heterologous challenge.
@nl
P2093
P2860
P1476
Dual-subtype feline immunodefi ...... gainst heterologous challenge.
@en
P2093
Chengjin Huang
Douglas Conlee
Hsien-Jue Steve Chu
Michael Gill
P2860
P304
P356
10.1016/J.JFMS.2009.12.016
P577
2010-02-18T00:00:00Z